Table 3.
Control | SM | ATL | SM+ATL | pa | pb | |
---|---|---|---|---|---|---|
N = 67 (32.0%) | N = 57 (28.0%) | N = 36 (17.0%) | N = 47 (23.0%) | |||
Hemoglobin (n = 207) | ||||||
Normal | 59 (88.0) | 53 (93.0) | 32 (89.0) | 44 (94.0) | 0.674 | 0.898 |
Altered | 8 (22.0) | 4 (7.0) | 4 (11.0) | 3 (6.0) | ||
Red blood cell (n = 207) | ||||||
Normal | 65 (97.0) | 56 (98.0) | 33 (92.0) | 47 (100) | 0.142 | 0.362 |
Altered | 2 (3.0) | 1 (2.0) | 3 (8.0) | 0 (0.0) | ||
Platelet (n = 207) | ||||||
Normal | 66 (98.5) | 52 (91.0) | 34 (94.5) | 45 (96.0) | 0.305 | 0.373 |
Altered | 1 (1.5) | 5 (9.0) | 2 (5.5) | 2 (4.0) | ||
Eosinophilia (n = 207) | ||||||
Absent | 41 (61.0) | 28 (49.0) | 29 (81.0) | 31 (66.0) | 0.022* | 0.085 |
Present | 26 (39.0) | 29 (51.0) | 7 (19.0) | 16 (34.0) |
Control, no S. mansoni infection or ATL history; SM, S. mansoni-infected only; ATL, ATL history only; SM+ATL, S. mansoni infection and ATL history; p-value obtained by chi-squared test;
Among all the groups;
Between SM and SM+ATL groups;
Statistically significant (p < 0.05).